The U.S. Food & Drug Administration has issued an urgent medical device correction for certain insulin pumps manufactured by ...

Tandem Diabetes Care, Inc. has issued an urgent correction for select pumps due to a possible error that could result in ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technolog ...

A problem with speakers in Tandem’s t:slim X2 insulin pumps can cause insulin delivery to stop, the company said.

The next big thing on Tandem Diabetes Care’s technology slate is actually a very small thing. The Mobi insulin pump—which is the company's smallest device to date and, it claims, the smallest ...

Tandem’s t:slim X2 insulin pump connects wirelessly to the FreeStyle Libre 2 Plus sensor, which sends automatic glucose readings every minute2,3 to the pump. Users can conveniently see their ...

Tandem Diabetes Care's insulin pump app isn't fixed after a March update. It has caused more than 100 people to need medical intervention.

The pairing with Tandem's pump marks Abbott's first closed-loop insulin delivery system in the U.S.

He noted that Tandem is already preparing for the pint-sized pump’s commercial launch following FDA clearance, which it’s tentatively expecting to snag in the first half of 2023.

The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company today announced the Tandem t: slim X2™ insulin pump with Control-IQ+ automated insulin delivery technology ...